19 May 2021 Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting Member news
11 May 2021 Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski Member news
11 May 2021 Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance Member news
11 May 2021 Sequana Medical announces strong top-line results from RED DESERT alfapump DSR® study and expansion of DSR® development programme Member news
07 May 2021 CD3 and VIB enter into an exclusive license and research collaboration with SpringWorks Therapeutics to develop TEAD inhibitors for addressing biomarker-defined cancers Member news
05 May 2021 Biocartis announces new collaboration with AstraZeneca to expand availability of Idylla™ EGFR biomarker testing among patients with lung cancer Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
